Abstract     Description     Claims     Drawing  

US62031302   [0001] 
US20100203559A   [0017] 
US20100233802A   [0017] 
US20100233741A   [0017] 
US8198034B   [0017] 
US57251207   [0027] 
US20090081730A   [0029] 
US776075   [0029] 
US20080241881A   [0029] 
US20110287517A   [0029] 
US20090069238A   [0029] 
US20110189162A   [0029] 
US201122272W   [0029] 
US331816   [0063] 
WO2010090677A   [0063] 
US7449192B   [0069] 
US8062807B   [0069] 
US7968104B   [0069] 

Remington's Pharmaceutical Sciences   [0017] 
Degradable Clostridial Toxins   [0027] 
Activatable Clostridial Toxins   [0029] 
Modified Clostridial Toxins with Enhanced Translocation Capabilities and Altered Targeting Activity For Non-Clostridial Toxin Target Cells   [0029] 
Modified Clostridial Toxins with Enhanced Translocation Capabilities and Altered Targeting Activity for Clostridial Toxin Target Cells   [0029] 
Degradable Clostridial Toxins   [0029] 
Activatable Clostridial toxins   [0029] 
Modified Clostridial Toxins Comprising an Integrated Protease Cleavage Site-Binding Domain   [0029] 
Methods of Intracellular Conversion of Single-Chain Proteins into their Di-chain Form   [0029] 
PHARMACEUTICAL DOSAGE FORMS AND DRUG DELIVERY SYSTEMS   [0062] 
REMINGTON: THE SCIENCE AND PRACTICE OF PHARMACY   [0062] 
GOODMAN & GILMAN'S THE PHARMACOLOGICAL BASIS OF THERAPEUTICS   [0062] 
HANDBOOK OF PHARMACEUTICAL EXCIPIENTS   [0062] 
Clostridial Toxin Pharmaceutical Compositions   [0063]